This announcement is a separate document:
康泰生物:关于董事会提议向下修正可转换公司债券转股价格的公告
Shenzhen Kangtai Biological Products: Announcement on the board of directors proposing to revise the conversion price of convertible corporate bonds downward
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.